These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 35584328)

  • 1. The senescence-associated secretory phenotype in ovarian cancer dissemination.
    Veenstra JP; Bittencourt LFF; Aird KM
    Am J Physiol Cell Physiol; 2022 Jul; 323(1):C125-C132. PubMed ID: 35584328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overcoming the senescence-associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer.
    Chambers CR; Ritchie S; Pereira BA; Timpson P
    Mol Oncol; 2021 Dec; 15(12):3242-3255. PubMed ID: 34137158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Link Between Senescence and Cell Fate: Senescence-Associated Secretory Phenotype and Its Effects on Stem Cell Fate Transition.
    Pan Y; Gu Z; Lyu Y; Yang Y; Chung M; Pan X; Cai S
    Rejuvenation Res; 2022 Aug; 25(4):160-172. PubMed ID: 35658548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bepotastine Sensitizes Ovarian Cancer to PARP Inhibitors through Suppressing NF-κB-Triggered SASP in Cancer-Associated Fibroblasts.
    Jin P; Li X; Xia Y; Li H; Li X; Yang ZY; Wang Z; Xu C; Fang T; Zhou D; Xiong X; Wang SY; Xu S; Gao Q
    Mol Cancer Ther; 2023 Apr; 22(4):447-458. PubMed ID: 36780236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic and scalable assessment of the senescence-associated secretory phenotype (SASP).
    Malaquin N; Rodier F
    Methods Cell Biol; 2024; 181():181-195. PubMed ID: 38302239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olaparib induced senescence under P16 or P53 dependent manner in ovarian cancer.
    Wang Z; Gao J; Zhou J; Liu H; Xu C
    J Gynecol Oncol; 2019 Mar; 30(2):e26. PubMed ID: 30740957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reshaping of the tumor microenvironment by cellular senescence: An opportunity for senotherapies.
    D'Ambrosio M; Gil J
    Dev Cell; 2023 Jun; 58(12):1007-1021. PubMed ID: 37339603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Keeping the senescence secretome under control: Molecular reins on the senescence-associated secretory phenotype.
    Malaquin N; Martinez A; Rodier F
    Exp Gerontol; 2016 Sep; 82():39-49. PubMed ID: 27235851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of senescence on the tumour microenvironment and response to therapy.
    Reynolds LE; Maallin S; Haston S; Martinez-Barbera JP; Hodivala-Dilke KM; Pedrosa AR
    FEBS J; 2024 Jun; 291(11):2306-2319. PubMed ID: 37873605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatial and Temporal Control of Senescence.
    Ito Y; Hoare M; Narita M
    Trends Cell Biol; 2017 Nov; 27(11):820-832. PubMed ID: 28822679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential Regulators of the Senescence-Associated Secretory Phenotype During Senescence and Aging.
    Han X; Lei Q; Xie J; Liu H; Li J; Zhang X; Zhang T; Gou X
    J Gerontol A Biol Sci Med Sci; 2022 Nov; 77(11):2207-2218. PubMed ID: 35524726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Senescence in head and neck squamous cell carcinoma: relationship between senescence-associated secretory phenotype (SASP) mRNA expression level and clinicopathological features.
    Ostrowska K; Niewinski P; Piotrowski I; Ostapowicz J; Koczot S; Suchorska WM; Golusiński P; Masternak MM; Golusiński W
    Clin Transl Oncol; 2024 Apr; 26(4):1022-1032. PubMed ID: 38175424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular Senescence as a Brake or Accelerator for Oncogenic Transformation and Role in Lymphatic Metastasis.
    Banerjee P; Gaddam N; Pandita TK; Chakraborty S
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing Functional Roles of the Senescence-Associated Secretory Phenotype (SASP).
    Malaquin N; Tu V; Rodier F
    Methods Mol Biol; 2019; 1896():45-55. PubMed ID: 30474839
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Zhang JW; Zhang D; Yin HS; Zhang H; Hong KQ; Yuan JP; Yu BP
    Gut Microbes; 2023; 15(1):2197836. PubMed ID: 37017266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inorganic arsenic exposure-induced premature senescence and senescence-associated secretory phenotype (SASP) in human hepatic stellate cells.
    Okamura K; Sato M; Suzuki T; Nohara K
    Toxicol Appl Pharmacol; 2022 Nov; 454():116231. PubMed ID: 36089002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin regulates PARP1 to control the senescence-associated secretory phenotype (SASP) in human fetal lung fibroblast cells.
    Yu S; Wang X; Geng P; Tang X; Xiang L; Lu X; Li J; Ruan Z; Chen J; Xie G; Wang Z; Ou J; Peng Y; Luo X; Zhang X; Dong Y; Pang X; Miao H; Chen H; Liang H
    J Pineal Res; 2017 Aug; 63(1):. PubMed ID: 28247536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of cellular senescence and SASP in tumour microenvironment.
    Takasugi M; Yoshida Y; Hara E; Ohtani N
    FEBS J; 2023 Mar; 290(5):1348-1361. PubMed ID: 35106956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The senescence-associated secretory phenotype (SASP) from mesenchymal stromal cells impairs growth of immortalized prostate cells but has no effect on metastatic prostatic cancer cells.
    Alessio N; Aprile D; Squillaro T; Di Bernardo G; Finicelli M; Melone MA; Peluso G; Galderisi U
    Aging (Albany NY); 2019 Aug; 11(15):5817-5828. PubMed ID: 31412320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rosiglitazone ameliorates senescence and promotes apoptosis in ovarian cancer induced by olaparib.
    Wang Z; Gao J; Ohno Y; Liu H; Xu C
    Cancer Chemother Pharmacol; 2020 Feb; 85(2):273-284. PubMed ID: 31907647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.